基金经理：杨桢霄
| 单位净值:4.0910 | 净值增长率:-9.03% | 净值增长率:-9.03% | 累计净值:4.0910 | 截止日期:2026/7/17 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:34.26亿元 | 风险等级:中高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
单位(元)易方达医疗保健行业混合A(110023)资产负债表 |
||||
|---|---|---|---|---|
| 报告期 | 2025/12/31 | 2025/6/30 | 2024/12/31 | 2024/6/30 |
| 资产 | ||||
| 银行存款 | 220,027,911 | 358,520,076 | 405,489,764 | 341,308,229 |
| 结算备付金 | 1,984,320 | 7,398,391 | 10,408,581 | 5,590,263 |
| 存出保证金 | 644,880 | 1,721,349 | 1,860,955 | 827,044 |
| 交易性金融资产 | 3,152,902,471 | 4,027,444,944 | 4,726,203,625 | 5,348,970,052 |
| 其中：股票投资 | 3,152,902,471 | 4,027,444,944 | 4,726,203,625 | 5,342,698,477 |
| 基金投资 | - | - | - | - |
| 债券投资 | - | - | - | 6,271,575 |
| 资产支持证券投资 | - | - | - | - |
| 衍生金融资产 | - | - | - | - |
| 买入返售金融资产 | - | - | - | - |
| 应收证券清算款 | 18,447,118 | 17,126,564 | 7,878,326 | - |
| 应收利息 | - | - | - | - |
| 应收股利 | - | - | - | - |
| 应收申购款 | 9,324,036 | 6,765,826 | 2,358,962 | 22,856,480 |
| 其他资产 | - | - | - | - |
| 资产总计 | 3,403,330,738 | 4,418,977,150 | 5,154,200,211 | 5,719,552,067 |
| 负债 | ||||
| 短期借款 | - | - | - | - |
| 交易性金融负债 | - | - | - | - |
| 衍生金融负债 | - | - | - | - |
| 卖出回购金融资产款 | - | - | - | - |
| 应付证券清算款 | 20,049,472 | 34,430,725 | 14,224,571 | - |
| 应付赎回款 | 19,178,441 | 68,256,503 | 124,561,490 | 17,471,554 |
| 应付管理人报酬 | 3,639,211 | 4,589,461 | 5,420,798 | 5,868,879 |
| 应付托管费 | 606,535 | 764,910 | 903,466 | 978,146 |
| 应付销售服务费 | 110,340 | 158,690 | 102,159 | 172,446 |
| 应付交易费用 | - | - | - | - |
| 应交税费 | - | - | - | 14 |
| 应付利息 | - | - | - | - |
| 应付利润 | - | - | - | - |
| 其他负债 | 1,257,620 | 3,170,596 | 3,578,250 | 2,517,998 |
| 负债合计 | 44,841,620 | 111,370,886 | 148,790,734 | 27,009,037 |
| 所有者权益 | ||||
| 实收基金 | 885,010,831 | 1,159,590,910 | 1,643,964,013 | 1,906,620,608 |
| 未分配利润 | 2,473,478,286 | 3,148,015,354 | 3,361,445,464 | 3,785,922,422 |
| 所有者权益合计 | 3,358,489,117 | 4,307,606,264 | 5,005,409,477 | 5,692,543,030 |
| 负债和所有者权益总计 | 3,403,330,738 | 4,418,977,150 | 5,154,200,211 | 5,719,552,067 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。